Fred Alger Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
Fred Alger Management's NVO Position: Q3 2026 in Review
Fred Alger Management sold out of Novo Nordisk (NVO) in Q3 2026, closing a stake of 4,907,570 shares — an estimated $235M sold.
Fred Alger Management first reported a position in NVO in Q2 2015 and held it in 24 quarters. The position peaked at $235M in Q2 2026. 1,215 funds tracked by Wall St. Rank hold NVO as of Q3 2026.
- Fred Alger Management reported no remaining Novo Nordisk position as of Q3 2026 after selling out during the quarter.
- Fred Alger Management sold 4,907,570 Novo Nordisk shares in Q3 2026, an estimated $235M.
- Fred Alger Management first reported a position in Novo Nordisk in Q2 2015 and held it in 24 quarters.
- Fred Alger Management's Novo Nordisk position peaked at $235M in Q2 2026.
- 1,215 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.
Based on Fred Alger Management's 13F filing for Q3 2026, filed 16 Nov 2026.